(Q63574080)
Statements
BREEZE-AD6 (English)
0 references
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis (English)
0 references
27 June 2018
0 references
10 February 2020
0 references
300
0 references
18 year
0 references